Steffen Thomas - 05 Jun 2025 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Reporting relationship: Director
Issuer ticker: AVXL
Reported as of: 05 Jun 2025
Net transaction value: +$45.25
SEC form: 4
Accepted by SEC: 09 Jun 2025, 17:30:47 UTC
Prior SEC filing: 02 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/Steffen Thomas

Key filing fact

Steffen Thomas filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 09 Jun 2025.

Key facts

This page summarizes Steffen Thomas's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2025, 17:30.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: +$45.25.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001646396 Primary reporting owner

Thomas Steffen

Relationship: Director
Address: 630 5TH AVENUE 20TH FLOOR, NEW YORK
Signature: /s/Steffen Thomas
Signature date: 09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVXL transaction

Common stock

Options Exercise

Transaction value: $88,000
Shares: +50,000
Change %: +1000%
Price: $1.76
Shares after: 55,000
Date: 05 Jun 2025
Ownership: Direct

AVXL transaction

Common stock

Tax liability

Transaction value: $87,955
Shares: -11,349
Change %: -21%
Price: $7.75
Shares after: 43,651
Date: 05 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVXL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -50,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $1.76
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on June 15, 2025. The reporting person received 38,651 shares of common stock on net exercise of an option to purchase 50,000 shares of common stock. The Company withheld 11,349 shares of common stock underlying the option as consideration for the exercise price, using the average of the high and low sales price on June 5, 2025 of $7.75, pursuant to the terms of the Company's 2007 Stock Option Plan.

Footnote F2

The options vested in three equal annual installments beginning on June 15, 2016